ICAP at Columbia’s Mailman School of Public Health has been awarded funding from the Centers for Disease Control and Prevention (CDC) through PEPFAR to support the Government of Angola in developing high-quality HIV care systems that contribute to decreasing morbidity and mortality among HIV-infected individuals and to reducing the transmission of HIV to others.
Through this project, ICAP is partnering with Angola’s National Institute in the Fight against AIDS (INLS) to strengthen HIV testing, care and treatment in Luanda Province. Working at the facility level, ICAP will provide targeted technical assistance to increase access to HIV testing for families, strengthen integration of HIV and TB programs, and improve systems for timely initiation of antiretroviral treatment (ART), patient retention and viral suppression.
In addition, ICAP will build capacity at the national and sub-national level to assess HIV and HIV/TB clinical program data quality, and will train health facility staff in applying quality improvement methods to improve patient care. More than 2.3 million people have received HIV care through ICAP and more than 1.4 million have received life-saving antiretroviral therapy through ICAP-supported programs.
“Angola has made significant strides towards rebuilding its health system after decades of civil war. Leadership in-country is to be lauded for their commitment to addressing gaps in the continuum of care for HIV and to the collection and utilization of data to effectively guide HIV programs and policy,” said ICAP director Dr. Wafaa El-Sadr, Mailman School professor of epidemiology and medicine.
There are currently over 270,000 adults and 30,000 children living with HIV in Angola. More than half are in need in of ART.
This project builds on ICAP’s strong track record providing implementation support and technical assistance for HIV programs in post-conflict settings.